| Financial Year |
March 31 2023 |
| Monetary Funds |
34,484,540.15 |
| Held-for-trading Financial Assets |
3,720,354.55 |
| Notes Receivable |
2,246,974.51 |
| Accounts Receivable |
23,192,327.76 |
| Advances to Suppliers |
6,308,159.16 |
| Other Receivables |
11,554,642.72 |
| Amounts Due From Related Companies |
-- |
| Interest Receivable |
-- |
| Dividend Receivable |
-- |
| Inventories |
63,272,691.17 |
| Among: Consumptive Biological Assets |
-- |
| Non-Current Assets Maturing Within One Year |
-- |
| Other Current Assets |
2,437,726.73 |
| Total Current Assets |
153,972,239.99 |
| Available-for-Sale Financial Asset |
-- |
| Held-to-maturity Investments |
-- |
| Long-Term Account Receivable |
-- |
| Long-term Equity Investment |
-- |
| Investment Properties |
-- |
| Fixed Assetes |
75,036,158.37 |
| Under-construction Projects |
320,418.64 |
| Construction Materials |
-- |
| Disposal of Fixed Assets |
-- |
| Capitalized Biological Assets |
-- |
| Oil and Gas Assets |
-- |
| Intangible Assets |
7,321,954.39 |
| R&D expenses |
-- |
| Goodwill |
-- |
| Long-Term Deferred and Prepaid Expenses |
701,511.10 |
| Deferred Income Tax Assets |
16,442,313.18 |
| Other Non-Current Assets |
97,347,415.47 |
| Sub-Total of Non-Current Assets |
213,399,670.92 |
| Total Assets |
367,371,910.91 |
| Short-Term Loans |
18,400,000.00 |
| Trading Financial liabilities |
5,000,000.00 |
| Notes Payable |
-- |
| Accounts Payable |
75,399,174.70 |
| Accounts Received In Advance |
-- |
| Employee Compensation Payable |
5,497,972.44 |
| Taxes Payable |
1,114,312.28 |
| Interest Payable |
2,479,666.01 |
| Dividend Payable |
-- |
| Other payables |
15,996,763.93 |
| Due to Related Companies |
-- |
| Non-Current Liabilities Due Within One Year |
3,012,294.45 |
| Other Current Liabilities |
1,766,220.30 |
| Sub-Total of Current Liabilities |
149,409,754.10 |
| Long-term Loans |
-- |
| Bonds Payable |
-- |
| Long-Term Accounts Payable |
95,035,847.72 |
| Special Payable |
-- |
| Estimatied Liabilities |
-- |
| Deferred Income Tax Liabilities |
6,407,155.76 |
| Other Non-Current Liabilities |
-- |
| Sub-Total of Non-Current Liabilities |
117,503,694.28 |
| Total Liabilities |
266,913,448.38 |
| Paid-In Capital(Or Share Stock) |
151,200,000.00 |
| Capital Surplus |
78,905,345.40 |
| Surplus Reserve |
14,311,069.14 |
| LESS:Treasury Stock |
-- |
| Undistributed Profits |
-154,397,660.28 |
| Minority Stockholder's Interest |
10,165,656.05 |
| Foreign Currency Capital |
-- |
| Abnormal Management Project Income Adjusted |
-- |
| Total Owners' Equity Attributable to Parent(Stockholder's Interest) |
90,292,806.48 |
| Owner's Equity（Stockholder's Equity） |
100,458,462.53 |
| Total Liabilities and Owner's Equity（Stockholder's Equity） |
367,371,910.91 |
